Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate the utility of d-cycloserine (DCS) for enhancing the effect of
a novel psychosocial intervention, imagery rescripting (ImRs), in adults with mild to
moderate PTSD symptoms after experiencing a traumatic event such as sexual or physical
assault, serious accident, etc. Participants will receive 4 sessions of either cognitive
behavioral therapy with imagery rescripting or cognitive behavioral therapy with imaginal
exposure and will receive study medication (DCS or Pill placebo) prior to Session 2 and
Session 3.